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The National Institute of Diabetes and Digestive Disease (NIDDK) Central Data Repository (CDR) is a web-enabled resource
available to researchers and the general public. The CDR warehouses clinical data and study documentation from NIDDK
funded research, including such landmark studies as The Diabetes Control and Complications Trial (DCCT, 1983–93) and the
Epidemiology of Diabetes Interventions and Complications (EDIC, 1994–present) follow-up study which has been ongoing
for more than 20 years. The CDR also houses data from over 7 million biospecimens representing 2 million subjects. To help
users explore the vast amount of data stored in the NIDDK CDR, we developed a suite of search mechanisms called the
public query tools (PQTs). Five individual tools are available to search data from multiple perspectives: study search, basic
search, ontology search, variable summary and sample by condition. PQT enables users to search for information across
studies. Users can search for data such as number of subjects, types of biospecimens and disease outcome variables without
prior knowledge of the individual studies. This suite of tools will increase the use and maximize the value of the NIDDK




Data repositories have become prevalent in the past
decade, storing vast banks of specialized data that support
a myriad of research fields. When genetics became a key
component of all biological research, the number of dis-
ease- and health-related databases increased rapidly.
Data from clinically annotated biospecimens provide
researchers with a precious resource for additional genetic
studies without the cost of collecting and testing. The
databases also provide the added benefit of increased
statistical power by facilitating pooling of data from mul-
tiple study populations.
The National Institute of Diabetes and Digestive Disease
(NIDDK) Central Data Repository (CDR) is one such data
repository. The NIDDK CDR is a web-enabled resource
that catalogs clinical research data and supporting mater-
ials from NIDDK funded studies (1, 2). It also acts as a
warehouse for clinical findings and biospecimen and
genetic data from completed research projects. Other
comparable data repositories include the Database of
Genotypes and Phenotypes (dbGaP) developed at the
.............................................................................................................................................................................................................................................................................................
Published by Oxford University Press on behalf of US Government 2013.
Page 1 of 11
(page number not for citation purposes)
Database, Vol. 2013, Article ID bas058, doi:10.1093/database/bas058
.............................................................................................................................................................................................................................................................................................
National Institutes of Health (NIH) National Center for
Biotechnology Information (NCBI) (3), the Biologic
Specimen and Data Repository Information Coordinating
Center (BioLINCC) (https://biolincc.nhlbi.nih.gov/studies/)
developed at the National Heart, Lung and Blood
Institute (NHLBI), the cancer Human Biobank (caHUB) (4)
developed at the National Cancer Institute (NCI) Office of
Biorepositories and Biospecimen Research (OBBR) and the
Promoting Harmonisation of Epidemiological Biobanks in
Europe (PHOEBE) (http://www.phoebe-eu.org). Despite
the significance of these NIH agency and European data
and biospecimen repositories, their broad-based impact
may be limited by the small number of publications avail-
able which describe the repositories.
Currently, the NIDDK CDR has data from 40 studies avail-
able for request. An additional 54 ongoing studies are
being tracked or curated. The CDR contains data for 40
sample types, over 6 million biospecimens representing 2
million subjects from 94 studies/networks. Genotype data
are available in the CRD for some studies. Genomic data
from the NIDDK Genome-Wide Association Studies
(GWAS) are deposited in dbGaP and the NIDDK CDR has
links to the studies in dbGaP.
To help users explore the vast amount of data and bios-
pecimens stored in the NIDDK CDR, we developed a suite of
search mechanisms called the public query tools (PQTs). In
this article, we describe the design and development of PQT
and how it assists users to find study information, data and
biospecimens in the CDR. Funded by the NIH American
Recovery and Reinvestment Act (ARRA) of 2009, the PQT
suite gives users new capabilities to perform cross-study
searches without prior knowledge of each individual study.
Design
Researchers can visit the public website (https://www.niddk
repository.org/niddk/home.do) to learn about the CDR con-
tents and identify studies of interest. Website users have
access to study protocols, sample information, study
metadata, data collection forms and study publications.
However, to review actual data values, researchers have
had to first submit a formal request and gain NIDDK
approval for a proposed investigation. This proposal-
specific approach has been time consuming and limited in
utility because researchers often need to see data before
finalizing a proposed project. Consequently, interested re-
searchers would generally contact CDR staff with questions
about the data before going through a formal request
process.
To provide quicker access to data for CDR users, we de-
veloped the PQT suite to address the question ‘what’s in
the NIDDK CDR?’ PQT helps users explore CDR contents
with a user friendly interface. The PQT caters to marked
differences in user scope by producing results with a
range of granularity, from general to very specific. For in-
stance, a user may seek available subjects or samples from
studies that have African-American subjects with diabetes
who are 50 years of age or older. PQT is able to provide the
result quickly and easily.
Although there may be many ways to query the contents
of the CDR, for PQT, we chose user perspective as our
design starting point. Through our design assessment, we
defined the following three user perspectives.
 Design focused user is interested in identifying studies
by traits such as purpose, principal findings and main
design elements. This user is looking for studies with
specific methods and treatment that may provide in-
sight for the design of new studies. Variables needed
are study design, treatment (if the design is a clinical
trial), duration, principal findings and study outcomes.
 Disease focused user seeks data from a variety of clin-
ical studies to develop a unified view across study sub-
jects. This user searches for commonality of health
factors from different but related studies and is inter-
ested in viewing studies that follow different protocols
about the same disease type. For this perspective, vari-
ables from multiple studies are compared for the
underlying and undiscovered properties related to a
disease and its treatment. These variables include
those that examine the extent of the disease (e.g.
serum creatinine levels) and confounders (e.g. blood
pressure and age) from multiple studies within a dis-
ease domain.
 Casual user is interested in identifying the various types
and breadth of studies in the CDR that are available to
researchers. Users with this perspective are looking for
broad level attributes and study descriptions.
After clarifying the perspectives, we identified the kinds
of data elements that were needed to yield the desired
result. This process revealed that certain data elements
were common to all perspectives, while others were only
needed for a more in-depth searching of users focusing on
disease. Our assessment of data elements resulted in spe-
cific groupings of data for each study in the CDR. The as-
sessment process also clarified functionality and user
interface requirements and led us to develop the distinct
PQT search tools that are now available for public use at
the CDR website (Figure 1). The tools include the study
search tool, basic search tool, ontology search tool, variable
summary tool and samples by condition search tool. Each
tool is discussed later in ‘PQT suite’ section.
Develop data tables
Because actual study data files are only accessible to reques-
tors approved by the NIDDK CDR Reviewer Panel, we must
specially prepare the variables that power the search tools.
.............................................................................................................................................................................................................................................................................................
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Identifying and importing these data into structured data
tables that link to the tools have been a labor intensive
process performed by project staff who work closely with
the study data and understand the priority of data elem-
ents to research objective. However, the benefit is clear—
once in place, these data are able to simply and easily pro-
vide a user with the response to a query such as, ‘what
studies have data on retinopathy?’
Identifying and compiling PQT variables
The team developed three categories of data to drive the
PQT: study metadata, disease domain variables and
common standardized variables.
Study metadata. Specific characteristics are identified
to provide a snapshot of each study in the CDR so that
users can easily review the most salient aspects at a
glance. The Repository staff review study materials when
adding a study to the CDR to extract these characteristics,
which are used as data elements by the PQT. A complete list
of metadata elements is shown in Table 1. The study meta-
data is most closely aligned with the basic search tool
within the PQT suite but is also accessed by the ontology
search and study search tools.
Disease domain variables. The ability to compare data
across studies is important for researchers whose work
focuses on a specific disease. For PQT, we constructed cate-
gories called ‘disease domains’ into which repository studies
fall. The disease domain tables are populated with variables
whose ‘content’ is drawn from study datasets, with up to 40
of the most important variables from each study extracted
for use in PQT. The disease domains allow a user to com-
pare same or similar variables across studies. PQT employs
concept harmonization, not derivation, which means that
specific study variables are mapped to disease domain
Figure 1. PQT suite of tools at NIDDK CDR website.
.............................................................................................................................................................................................................................................................................................
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variables while still preserving the variable’s study-specific
definition. The variable description and name are harmo-
nized, whereas units, statistical formulas used to calculate
composite variables, data groupings and distribution (con-
tinuous versus categorical) are not. This limited harmoniza-
tion maintains unique study definitions of variables while
providing the user with a method for linking similar meas-
ures across studies.
For example, the domain variable ‘hxneuropathy’, or
history of neuropathy, is a diabetes domain element. The
GoKinD and EDIC studies both collected this data. The
GoKinD measure is a history of severe symptomatic periph-
eral neuropathy collected via questionnaire, as 1 = yes,
0 = no and 3 = unknown. The EDIC measure is a clinical diag-
nosis of neuropathy at the close of the parent study, DCCT,
where 1 = definite, 2 = possible and 3 = none. Both GoKinD
and EDIC study-specific measures were mapped to the
domain variable ‘hxneuropathy’; however, the study-
specific definitions of each were preserved and may be
referenced using the variable summary tool, described
later in the ‘PQT suite’.
To date, variables pertaining to three disease domains
are included in PQT: diabetes, kidney disease and liver dis-
ease. Variables relevant to these domains were identified
through a literature search and by consulting with disease
experts. Because some of the same elements are associated
with more than one disease domain, there is overlap be-
tween variables of different domains. Table 2 shows how
studies fall into multiple disease domains. In the future, we
intend to increase the number of disease domains, adding a
domain when more than two relevant studies have been
submitted to the repository.





 Covariates related to outcomes.
 History of disease.
 Outcomes.
 Physical and lab measurements.
Currently, the three disease domains in Table 2 incorpor-
ate 119 distinct variables, with 10 demographics variables
belonging to all three domains. Please note that some of
the demographics variables overlap with other common
standardized variables as described in the next section.
Common standardized variables. To identify a
common set of broad-based variables across all clinical
and genetic studies in the repository, we adopted the NCI
Common Biorepository Model (CBM). Although the CBM
is designed to describe biospecimens, the variables also
supply characteristics of a research subject. By using the
CBM standard variables, we were able to describe the
subject as well as the samples associated with the subject
and, most importantly, illustrate NIDDK’s support for a
standard method of annotating samples across all research
projects.
PQT uses 15 of the 30 established CBM variables. Most
are populated by a yes/no field (i.e. those starting with ‘Has’
in Table 3); however, some contain values abstracted from
study data. Some CBM variables can be directly mapped to
a study variable. For example, the race of a patient may
have been recorded during data collection and is pulled
into the variable CBM ‘Race’. Others are derived from a
review of study data. For example, the ‘hasLabdata’ vari-
able will be derived from the study dataset called ‘Labs’,
which has information on several measurements on the pa-
tient such as cholesterol, creatinine and glucose. The pres-
ence of information for any one of the variables in the Labs
dataset will imply that: hasLabdata = yes. Table 3 shows the
CBM variables used within PQT.
Align data to PQT
Tables containing the required data are integrated into the
CDR database to support the search tools, as illustrated in
Table 1. Metadata sources for basic and ontology search tools
used for PQT suite
Metadata sources for basic and ontology search tools
No. study subjects Image data availability
Condition Transplant patient
Study design Dialysis patient
Treatment/intervention Duration of study
Main outcome measures Objective
Study outcome Selection criteria
Stored samples # Recruitment sites
Non-GWAS data availability dbGaP GWAS data link




Studies in the CDR




AASK Trial, AASK Cohort, ATN, CDS,CRIC, CRISP,
DCCT/EDIC, DAC-FISTULA, DAC-GRAFT, FIND,




A2ALL, HALT-C, LTD, LTD2, PEDS-C and
VIRAHEP-C
aSee Table A1 for the list of full study names.
.............................................................................................................................................................................................................................................................................................
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Figure 2, which maps the data table to the tool. The 12
tables are grouped as follows: study, ontology nodes, dis-
ease domains, variables and samples. For PQT to operate,
the data are uploaded to these tables within the central
database.
The data are systematically compiled and passed to
the development team, who then initiate the data loading
program to make the data available to search. The program
parses, analyzes and validates the data against defined
database/business rules. After validation, the data are
loaded into the core PQT tables shown above and are avail-
able to users.
PQT suite
In this section, we describe the final set of query tools that
resulted from the design process. Table 4 lists each of the
five tools with their distinctive search methods and results.
Study search tool
The study search tool provides key information about each
study including metadata and study materials. Users select
a study by name in the study search interface. This action
brings up a table showing the availability of samples, geno-
type data and a link to the selected study. Users can follow
the link to find a metadata table with key information
about the study such as disease condition, study design,
objective, selection criteria, outcomes and other items.
This page also includes a link to the study page that
includes a general description, the study protocol, manual
of operations, data forms and a roadmap report describing
Figure 2. CDR PQT suite tables supporting the query tools.
Table 3. List of CBM variables used by the PQT suite
CBM variable





6 Has additional patient demographics data
7 Has family history data
8 Has histopathologic data
9 Has exposure history data
10 Has lab data
11 Has treatment information
12 Has outcome information
13 Has longitudinal specimens
14 Has matched specimens
15 Year sample first preserved/stored
.............................................................................................................................................................................................................................................................................................
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the data archive. It also identifies a primary publication and
displays a replication report, the data dictionary and study
samples.
Basic search tool
The basic search tool identifies studies based on user-
defined criteria. The user selects from dropdown lists that
are a subset of study metadata categories:
 Condition studied—benign prostatic hyperplasia
(includes enlarged prostate and prostatitis), chronic
pelvic pain, cirrhosis, coronary heart disease (includes
cardiovascular disease), Crohn’s disease, diabetes
Type 1, diabetes Type 2, hepatitis C, hypertension,
hypogonadism, impaired glucose tolerance, inflamma-
tory bowel disease, interstitial cystitis, kidney disease,
liver disease, neuropathy, retinopathy, sexual dysfunc-
tion and urinary incontinence (includes incontinence
and stress urinary incontinence and urogynecologic).
 Study design—case-control, clinical trial, cross-sectional,
genetic, longitudinal, observational, prospective, retro-
spective and survey.
 Intervention/treatment—behavioral, dialysis, drug ther-
apy, liver/kidney, transplant, nutrition and surgery.
Figure 3. Screenshot showing the predefined categories of ‘Specialty Characteristics’.
Table 4. PQT search methods and results
PQT tools Search methods Search results
Study search tool Select predefined study name. Study name linked to study metadata and documents.
Basic search tool Select predefined study metadata categories. Study name linked to study metadata and documents.
Ontology search tool Enter keyword to search study metadata. Study name linked to study metadata and documents.
Variable summary tool Select from predefined variables. Variable counts/frequency in studies.
Sample by condition search tool Select predefined disease conditions. Biospecimen types and counts by study.
.............................................................................................................................................................................................................................................................................................
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In addition, the basic search offers predefined queries
with the following specialty characteristics:
 Studies with genotype data (GWAS and non-GWAS).
 Studies with subjects who are dialysis patients.
 Studies with subjects who have had a liver or kidney
transplant.
 Studies with associated image data (CT, MRI and
ultrasound).
 Studies with subjects under 18 years of age.
The tool also allows identifying studies by the types of
samples stored in the central bio-repositories:
 Sample availability—DNA, buffy coat, PBMC, plasma,
serum, tissue and others.
Researchers set criteria on the main basic search page
(Figure 3). Result displays studies matching all criteria in a
table that includes stored sample types and availability of
genotype data. Study names shown in the table are hyper-
linked to a study metadata and another link to all stored
study materials, including the protocol and data forms.
Ontology search tool
The ontology search tool identifies studies via keyword
search through CBM variables that have been mapped to
the NCI Metathesaurus. The ontology supporting this tool
was constructed to deliver maximum search results for user
specifications. For example, searching ‘diabetes mellitus’
will find studies that reflect: ‘diabetes’, ‘Type 1 diabetes’,
‘diabetes, Type 1’, ‘diabetes Type 2’ and ‘Type 1 diabetes’.
This search strategy increases the sensitivity of returned
results with a minimal specificity trade-off.
In addition to the NCI-Metathesaurus-based ontology
search, the tool also runs the search in full-text through
select study metadata items (outcome measures, condition,
outcome, objective, design and criteria). The tool combines
results from both searches and presents it to the user. The
algorithms aim to provide both high specificity and high
sensitivity. The ontology search tool also provides the
following two convenient features to the user:
 Search within the search result allows users to narrowq
or filter the search results using additional search terms.
 View search path allows users to view the hierarchy of the
search path, showing the relationship between the key-
word searched and the term found in the study metadata.
Variable summary tool
The variable summary tool allows users to compute sum-
mary statistical reports for key variables relating to study
Figure 4. Screenshot showing summary statistics of number of subjects for two variables (gender and history of neuropathy) in
the EDIC Study in the single study view.
.............................................................................................................................................................................................................................................................................................
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subjects. The project team cataloged a core set of variables
from each study to support queries. Users select from these
core sets and the tool identifies studies that contain the
variables. Users can select up to three variables per query
to generate summary reports for variable value range and
subject counts. The tool generates reports to show continu-
ous and categorical variables for selected demographic and
clinical characteristics in archived studies.
This tool has two views.
For the ‘single study view’, users first select a study from
a dropdown list. Then, users can identify up to three meas-
ures from that study. Results are summarized as ranges (for
continuous variables) or as frequencies (for categorical vari-
ables). If more than one variable is chosen, the report will
show a cross-tabulation, e.g. if neuropathy diagnosis and
gender are chosen, then frequencies of neuropathy diag-
nosis are shown separately for males and for females. See
Figure 4 for an example of this use-case.
For the ‘cross-study view’, again users select up to three
variables of interest. The tool produces a list of studies
that have all selected variables. Users can then select the
studies for which they seek descriptive statistics. Data from
each selected study pops up in its own window. This
presentation makes it easier to compare and contrast simi-
lar variables (such as age range) across multiple studies. See
Figure 5 for an example of this use-case.
As a reminder, the actual study data item(s) used to
support the presence of a domain variable may vary
across studies. Therefore, in Figure 5, the presence of neur-
opathy in EDIC includes values of ‘1’ (definite) and ‘2’ (pos-
sible) but in GoKinD, the only value is ‘1’ (yes). The tool
helps identify same or similar variables across studies to
support users’ research, not to perform data harmonization
within PQT. If needed, a user can find further detail on
study definition of the variables in the study documenta-
tion, which is easily accessible through a link from the sum-
mary tool.
Sample search tool
The sample search tool allows users to select a disease con-
dition from a dropdown list, and the tool presents studies
with matching biospecimens. The search result provides
study name, sample types, sample counts and subject
counts for samples stored in NIDDK Biorepositories. As illu-
strated in Figure 6, the result provides both sample and
subject counts for selected sample types by study.
Figure 5. Screenshot showing summary statistics of number of subjects for one variable (history of neuropathy) in two studies
(EDIC and GoKinD) in the cross-study view.
.............................................................................................................................................................................................................................................................................................
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Challenges, benefits and future
enhancements
The PQT suite has been very successful in accomplishing the
intended goals. Users can search enormous amounts of
data and quickly identify answers to questions. However,
the amount of effort to develop and maintain the tools is
not insignificant. Here, we discuss our challenges, the bene-
fits to the repository derived from PQT and possible future
enhancements.
Maintenance challenges
Tools like the PQT rely on accurate and timely alignment to
data in order to provide search results that answer a user’s
question. Data incorporated into the database through
routine registry tasks are not a maintenance concern be-
cause the information is updated routinely. This includes
the biological sample information that powers the study
search, basic search, sample search and ontology search
tools.
However, the data elements that feed the variable
summary tool are extracted manually from study data
and uploaded to the database, a process now performed
by data analysts and involving multiple steps before the
data are available for search. We will continue to explore
more efficient methods for performing this process because
these tables drive one of the most unique tools in the PQT
suite. A possible alternative we are exploring is a text-based
search of variable names in study data files to identify pos-
sible matches to the harmonized variable name. Once po-
tential matches are identified, the analyst can more easily
review and select within a user interface that copies the
selected item into the database. This process will require
intensive testing for acceptability but could be a time
saving measure that would make maintenance faster and
data available to search soon after a study is added to the
repository.
Performance and security
The PQT is accessed through the NIDDK repository website.
Data to support a query are stored in the central database
that resides behind the RTI’s secure firewall. When a user
submits a query, the data are parsed from the database to
produce the result on the webpage. Generally, results are
displayed in real time with no noticeable delay for the user.
However, if a large amount of data are required for a cross
tab search, the results require more time. The project team
is investigating speed time improvements to reduce the
delay for displaying these types of results.
Figure 6. Search result of sample types for condition ‘Cirrhosis’.
.............................................................................................................................................................................................................................................................................................
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Quality control support
PQT has become a valuable tool for casual users and profes-
sional researchers and has provided unexpected additional
support to the CDR for monitoring registry progress and
conducting quality control spot checks on the registry data-
base. We now routinely run queries to check study details
such as sample tallies for material types and subject totals.
We also conduct queries to gain a better understanding of
the topic concentration of the research being funded by
NIDDK. These trend data are interesting to researchers
and to NIDDK because they can easily compare actual
trends against their own strategic plans.
Expansion of variables available to PQT
As discussed in the context of maintenance challenge, the
functionality of a query tool that is driven by actual study
data depends wholly on the variables included in the data
tables. While there are some follow-up measures such as
adverse events available through PQT, the tools primarily
access subject baseline data. Because many studies in the
repository are longitudinal in nature, an important future
development would be preparation and inclusion of
additional time points as well as specific variables.
Furthermore, we aim to expand the number of disease do-
mains so that study data from a wider variety of diseases is
available for review without submission of an official
request.
Conclusion
The NIDDK Central Repository was established to increase
the impact and extend the utility of valuable data and sam-
ples by making these materials available to the broader
scientific community. The new suite of PQT provides effect-
ive and flexible methods to search repository study data
and samples, allowing researchers to find content of inter-
est without prior knowledge of the studies. PQT opens up
the repository to a much larger user group to stimulate
research ideas and greater use of NIDDK data and biospeci-
mens which are an important resource to the disease
research community.
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Table A1. Study acronyms and full names
A2ALL The Adult-to-Adult Living Donor Liver Transplantation Cohort Study
AASK Trial The African American Study of Kidney Disease and Hypertension Study
AASK Cohort The African American Study of Kidney Disease and Hypertension Cohort Study
ATN The Acute Renal Failure Trial Network Study
CDS The Comprehensive Dialysis Study
CRIC Chronic Renal Insufficiency Cohort Study
CRISP The Consortium for Radiological Imaging Studies of Polycystic Kidney Disease
DAC—Fistula The Clopidogrel Prevention of Early AV Fistula Thrombosis Study
DAC—Graft The Aggrenox Prevention of Access Stenosis Study
DCCT/EDIC The Type 1 Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications
DPP Diabetes Prevention Program
DPPOS Diabetes Prevention Program Outcome Study
DPT-1 The Diabetes Prevention Type 1
FIND The Family Investigation of Nephropathy and Diabetes
GoKinD The Genetics of Kidneys in Diabetes
HALT-C The Hepatitis C Antiviral Long-term Treatment against Cirrhosis
HEALTHY Middle-School-Based Primary Prevention Trial of Type 2 Diabetes
HEMO The Hemodialysis Study
LookAHEAD Action for Health in Diabetes
LTD Liver Transplantation Database
LTD2 Liver Transplantation Database Followup
MDRD The Modification of Diet in Renal Disease
NANS National Analgesic Nephropathy Study
PEDS-C Pegylated Interferon Ribavirin for Children With HCV
PRIDE The Program to Reduce Incontinence by Diet and Exercise
T1DGC The Type 1 Diabetes Genetics Consortium
TEDDY The Environmental Determinants of Diabetes in the Young
VIRAHEP-C The Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C
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